You are here: Industry Insights > cipla

News List

Cipla nurtures global vision for affordable drugs biospectrumasia
October 23, 2018
The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market
Cipla nurtures global vision for affordable drugs biospectrumasia
October 12, 2018
Cipla nurtures global vision for affordable drugs
Dr R Ananthanarayanan appointed as Cipla’s global COO financialexpress
August 16, 2018
He will oversee R&D, manufacturing, supply chain, the API business and the key geographies of North America, Europe and Emerging Markets
Cipla to acquire South African drug firm for $33M biospectrumasia
July 16, 2018
The drugmaker will acquire Mirren through wholly owned unit Cipla Medpro South Africa.
Cipla gets US FDA approval for Generic Sustiva financialexpress
June 29, 2018
Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Efavirenz Tablets 600mg from the United States Food and Drug Administration (US FDA).
Cipla receives final approval for testosterone injection financialexpress
June 29, 2018
Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Testosterone Cypionate Injection 100mg/ml and 200mg/ml from the United States Food and Drug Administration (US FDA).
Stempeutics partners with Cipla financialexpress
May 21, 2018
Biotech firm Stempeutics Research has inked an out-licensing deal with drug major Cipla for its stem cell therapy product Stempeucel, indicated for treating critical limb ischemia. “
Cipla launches authorised generic of Aloxi in the US expressbpd
March 27, 2018
The drug is indicated for prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy
Cipla ties up with Roche to sell 2 key drugs in India financialexpress
March 01, 2018
Roche will be able to focus on bringing new, transformative medicines to patients in India
Cipla receives US FDA approval for generic Pulmicort Respules expressbpd
November 20, 2017
The drug is indicated for the maintenance treatment of asthma and as prophylactic therapy in children 12 months to 8 years of age

Previous page 1 2 3 4 5 6 7 8 Next page